Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peroxiredoxins | 13 | 2019 | 116 | 3.000 |
Why?
|
| Models, Molecular | 14 | 2019 | 193 | 2.310 |
Why?
|
| Hydroxyproline | 7 | 2019 | 9 | 2.270 |
Why?
|
| Hyperoxaluria, Primary | 6 | 2019 | 7 | 2.180 |
Why?
|
| Oxidoreductases | 7 | 2019 | 26 | 1.690 |
Why?
|
| Alcohol Oxidoreductases | 4 | 2015 | 6 | 1.360 |
Why?
|
| Cysteine | 10 | 2019 | 138 | 1.310 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 8 | 2018 | 12 | 1.130 |
Why?
|
| Proline Oxidase | 3 | 2019 | 4 | 1.090 |
Why?
|
| Oxidation-Reduction | 14 | 2019 | 268 | 0.970 |
Why?
|
| Crystallography, X-Ray | 10 | 2018 | 90 | 0.910 |
Why?
|
| Oxo-Acid-Lyases | 2 | 2012 | 2 | 0.820 |
Why?
|
| Mitochondria | 6 | 2016 | 186 | 0.800 |
Why?
|
| Recombinant Proteins | 8 | 2018 | 247 | 0.800 |
Why?
|
| Amino Acid Sequence | 10 | 2019 | 283 | 0.680 |
Why?
|
| Hydrogen Peroxide | 2 | 2018 | 83 | 0.590 |
Why?
|
| Substrate Specificity | 6 | 2015 | 86 | 0.590 |
Why?
|
| Acyl Coenzyme A | 1 | 2015 | 5 | 0.540 |
Why?
|
| Protein Structure, Quaternary | 3 | 2011 | 18 | 0.530 |
Why?
|
| Binding Sites | 7 | 2015 | 130 | 0.510 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2015 | 6 | 0.510 |
Why?
|
| Flavoproteins | 1 | 2015 | 6 | 0.510 |
Why?
|
| Ubiquinone | 1 | 2015 | 7 | 0.510 |
Why?
|
| Enzyme Inhibitors | 4 | 2016 | 164 | 0.500 |
Why?
|
| Protein Engineering | 3 | 2015 | 19 | 0.500 |
Why?
|
| Catalytic Domain | 6 | 2019 | 65 | 0.500 |
Why?
|
| Protein Structure, Tertiary | 7 | 2009 | 99 | 0.470 |
Why?
|
| Lactones | 2 | 2016 | 10 | 0.430 |
Why?
|
| Humans | 32 | 2019 | 31836 | 0.430 |
Why?
|
| Aloe | 1 | 2012 | 1 | 0.420 |
Why?
|
| Encephalomyocarditis virus | 1 | 2012 | 1 | 0.420 |
Why?
|
| Plants, Genetically Modified | 1 | 2012 | 3 | 0.420 |
Why?
|
| Oxalates | 3 | 2019 | 4 | 0.420 |
Why?
|
| Seeds | 1 | 2012 | 10 | 0.420 |
Why?
|
| Peroxidases | 2 | 2019 | 35 | 0.420 |
Why?
|
| Mutation | 7 | 2019 | 487 | 0.410 |
Why?
|
| Hyperoxaluria | 1 | 2011 | 1 | 0.410 |
Why?
|
| Interferon-alpha | 1 | 2012 | 70 | 0.400 |
Why?
|
| Protein Conformation | 6 | 2015 | 84 | 0.400 |
Why?
|
| Plant Extracts | 1 | 2012 | 61 | 0.390 |
Why?
|
| Antiviral Agents | 1 | 2012 | 108 | 0.390 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 355 | 0.390 |
Why?
|
| Mice | 7 | 2019 | 2476 | 0.390 |
Why?
|
| Biocatalysis | 3 | 2015 | 20 | 0.370 |
Why?
|
| Animals | 14 | 2019 | 7450 | 0.370 |
Why?
|
| Glycolates | 2 | 2019 | 7 | 0.330 |
Why?
|
| Drug Design | 2 | 2008 | 43 | 0.320 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 78 | 0.320 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2009 | 62 | 0.320 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2005 | 27 | 0.310 |
Why?
|
| Thioredoxins | 2 | 2015 | 21 | 0.310 |
Why?
|
| Signal Transduction | 8 | 2019 | 687 | 0.300 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2019 | 56 | 0.300 |
Why?
|
| Movement | 1 | 2008 | 50 | 0.300 |
Why?
|
| Carrier Proteins | 2 | 2019 | 137 | 0.290 |
Why?
|
| Eukaryotic Cells | 1 | 2007 | 1 | 0.290 |
Why?
|
| Escherichia coli | 1 | 2007 | 85 | 0.280 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 34 | 0.280 |
Why?
|
| Sulfinic Acids | 3 | 2013 | 13 | 0.280 |
Why?
|
| Electrons | 1 | 2006 | 12 | 0.280 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2006 | 7 | 0.280 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 33 | 0.280 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2005 | 4 | 0.280 |
Why?
|
| Antineoplastic Agents | 3 | 2012 | 607 | 0.270 |
Why?
|
| Liver | 3 | 2015 | 482 | 0.270 |
Why?
|
| Retroviridae Infections | 1 | 2005 | 1 | 0.260 |
Why?
|
| Virus Integration | 1 | 2005 | 5 | 0.260 |
Why?
|
| Chromosomes | 1 | 2005 | 9 | 0.260 |
Why?
|
| Tumor Virus Infections | 1 | 2005 | 21 | 0.260 |
Why?
|
| Phosphorylation | 5 | 2019 | 230 | 0.250 |
Why?
|
| Disulfides | 3 | 2019 | 36 | 0.240 |
Why?
|
| Peroxides | 3 | 2019 | 32 | 0.240 |
Why?
|
| Kinetics | 4 | 2015 | 209 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 766 | 0.230 |
Why?
|
| Hydrolysis | 2 | 2015 | 35 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2015 | 398 | 0.210 |
Why?
|
| Mass Spectrometry | 3 | 2017 | 103 | 0.200 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 493 | 0.180 |
Why?
|
| Kidney | 3 | 2019 | 515 | 0.180 |
Why?
|
| Amino Acid Motifs | 2 | 2018 | 24 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2015 | 70 | 0.170 |
Why?
|
| Tyrosine | 1 | 2019 | 23 | 0.170 |
Why?
|
| Cannabinoids | 1 | 2019 | 41 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2019 | 18 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2009 | 53 | 0.160 |
Why?
|
| Nitrogen | 1 | 2018 | 10 | 0.160 |
Why?
|
| Oxalic Acid | 1 | 2018 | 1 | 0.160 |
Why?
|
| Proteomics | 1 | 2018 | 94 | 0.150 |
Why?
|
| Ligands | 2 | 2015 | 80 | 0.150 |
Why?
|
| Phenols | 1 | 2017 | 17 | 0.150 |
Why?
|
| Sulfones | 1 | 2017 | 21 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2017 | 32 | 0.150 |
Why?
|
| Tetrazoles | 1 | 2017 | 61 | 0.150 |
Why?
|
| Methionine Sulfoxide Reductases | 2 | 2007 | 3 | 0.140 |
Why?
|
| Protein Binding | 3 | 2016 | 201 | 0.140 |
Why?
|
| Molecular Structure | 2 | 2017 | 59 | 0.140 |
Why?
|
| Acyl Carrier Protein | 1 | 2015 | 3 | 0.130 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2015 | 3 | 0.130 |
Why?
|
| Fatty Acids, Volatile | 1 | 2015 | 9 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 12 | 0.130 |
Why?
|
| Molecular Weight | 1 | 2015 | 41 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2013 | 33 | 0.130 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 25 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1012 | 0.130 |
Why?
|
| Models, Biological | 4 | 2017 | 391 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2019 | 444 | 0.130 |
Why?
|
| Thiostrepton | 1 | 2015 | 2 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 760 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 114 | 0.130 |
Why?
|
| Furans | 1 | 2015 | 3 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2016 | 52 | 0.130 |
Why?
|
| Proline | 1 | 2015 | 12 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2015 | 14 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2015 | 39 | 0.120 |
Why?
|
| Sulfenic Acids | 2 | 2018 | 54 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2015 | 64 | 0.120 |
Why?
|
| Apoptosis | 1 | 2016 | 354 | 0.120 |
Why?
|
| Oxidants | 1 | 2013 | 14 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2013 | 135 | 0.110 |
Why?
|
| Mortierella | 1 | 2013 | 1 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 2013 | 6 | 0.110 |
Why?
|
| Male | 6 | 2019 | 19091 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2013 | 48 | 0.110 |
Why?
|
| Glutarates | 1 | 2012 | 1 | 0.110 |
Why?
|
| Ketoglutaric Acids | 1 | 2012 | 5 | 0.110 |
Why?
|
| CHO Cells | 1 | 2012 | 24 | 0.110 |
Why?
|
| Cricetinae | 1 | 2012 | 39 | 0.110 |
Why?
|
| Genome, Plant | 1 | 2012 | 1 | 0.100 |
Why?
|
| Plant Leaves | 1 | 2012 | 6 | 0.100 |
Why?
|
| Glucuronidase | 1 | 2012 | 12 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2012 | 51 | 0.100 |
Why?
|
| Transgenes | 1 | 2012 | 48 | 0.100 |
Why?
|
| Protein Structure, Secondary | 2 | 2012 | 47 | 0.100 |
Why?
|
| Carbon Isotopes | 1 | 2011 | 9 | 0.100 |
Why?
|
| Ephrin-A1 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Receptor, EphA2 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 26 | 0.100 |
Why?
|
| Transfection | 1 | 2012 | 191 | 0.100 |
Why?
|
| Apoenzymes | 1 | 2011 | 2 | 0.100 |
Why?
|
| Schiff Bases | 1 | 2011 | 2 | 0.100 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 725 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2011 | 22 | 0.100 |
Why?
|
| Solutions | 1 | 2011 | 35 | 0.100 |
Why?
|
| Cattle | 1 | 2011 | 103 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 161 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2013 | 257 | 0.100 |
Why?
|
| Bacteria | 1 | 2011 | 46 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 409 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 470 | 0.090 |
Why?
|
| Models, Chemical | 2 | 2008 | 34 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2012 | 833 | 0.090 |
Why?
|
| Cyclohexanones | 1 | 2010 | 18 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2011 | 508 | 0.090 |
Why?
|
| Biosensing Techniques | 1 | 2010 | 25 | 0.090 |
Why?
|
| Magnesium | 1 | 2009 | 30 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2009 | 29 | 0.080 |
Why?
|
| Proteins | 1 | 2010 | 144 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 39 | 0.080 |
Why?
|
| Glyoxylates | 1 | 2008 | 1 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2008 | 50 | 0.080 |
Why?
|
| Sulfates | 1 | 2008 | 2 | 0.080 |
Why?
|
| Protein Folding | 1 | 2008 | 29 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 18 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 80 | 0.080 |
Why?
|
| Catalysis | 1 | 2008 | 65 | 0.080 |
Why?
|
| Methionine | 1 | 2007 | 8 | 0.070 |
Why?
|
| Hela Cells | 2 | 2018 | 78 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 135 | 0.070 |
Why?
|
| Peptides | 2 | 2018 | 119 | 0.070 |
Why?
|
| Computational Biology | 1 | 2007 | 91 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2007 | 220 | 0.070 |
Why?
|
| Furin | 1 | 2005 | 3 | 0.070 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 7 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2005 | 46 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 64 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 70 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 85 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2016 | 168 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 147 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2017 | 96 | 0.060 |
Why?
|
| Female | 5 | 2019 | 19859 | 0.060 |
Why?
|
| GTP Phosphohydrolases | 1 | 2003 | 9 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2016 | 598 | 0.050 |
Why?
|
| Rats | 2 | 2016 | 1586 | 0.050 |
Why?
|
| Neoplasms | 1 | 2007 | 692 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 311 | 0.040 |
Why?
|
| Peroxynitrous Acid | 1 | 2019 | 7 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2019 | 31 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 61 | 0.040 |
Why?
|
| Peroxidase | 1 | 2019 | 31 | 0.040 |
Why?
|
| Nitrates | 1 | 2019 | 27 | 0.040 |
Why?
|
| Base Sequence | 1 | 2019 | 251 | 0.040 |
Why?
|
| Dimerization | 1 | 2019 | 23 | 0.040 |
Why?
|
| Epitopes | 1 | 2018 | 24 | 0.040 |
Why?
|
| Epilepsy | 1 | 2019 | 82 | 0.040 |
Why?
|
| Software | 1 | 2019 | 127 | 0.040 |
Why?
|
| Calcium | 1 | 2019 | 304 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 156 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 2017 | 6 | 0.040 |
Why?
|
| Creatinine | 1 | 2018 | 195 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2018 | 229 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 71 | 0.040 |
Why?
|
| Fatty Acid Synthesis Inhibitors | 1 | 2016 | 3 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2016 | 37 | 0.030 |
Why?
|
| Neurons | 1 | 2019 | 409 | 0.030 |
Why?
|
| Catalase | 1 | 2015 | 15 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 26 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 71 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 186 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 7 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2012 | 33 | 0.030 |
Why?
|
| Alanine | 1 | 2012 | 27 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 57 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 2603 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2010 | 7 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 60 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 74 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 44 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 77 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2005 | 10 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2005 | 16 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 9327 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2005 | 292 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 11824 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2003 | 2 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2003 | 8 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2003 | 10 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 2146 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 208 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 261 | 0.010 |
Why?
|